{"id":936458,"date":"2026-02-12T07:40:15","date_gmt":"2026-02-12T12:40:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/"},"modified":"2026-02-12T07:40:15","modified_gmt":"2026-02-12T12:40:15","slug":"inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/","title":{"rendered":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO"},"content":{"rendered":"

<\/p>\n

Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 <\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The DJS Law Group<\/a> reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (\u201cInovio\u201d or \u201cthe Company\u201d) (NASDAQ: INO<\/a>) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n

\nShareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n

CLASS PERIOD:<\/b> October 10, 2023 to December 26, 2025<\/p>\n

DEADLINE: <\/b>April 7, 2026<\/p>\n

CASE DETAILS: <\/b>According to the Complaint, the Company made false and misleading statements to the market. Manufacturing deficiencies with Inovio\u2019s CELLECTRA device were likely to cause delays in its filing of a BLA with the FDA. The Company did not gather the evidence necessary to support a priority review by the FDA. Based on these facts, Inovio\u2019s public statements were false and materially misleading throughout the class period.<\/p>\n

\nIf you are a shareholder who suffered a loss, contact us to participate<\/a>.<\/p>\n

WHY DJS LAW GROUP?<\/b> DJS Law Group\u2019s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

Join the case<\/a> to recover your losses.<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260212471736\/en\/<\/a><\/span><\/p>\n

\nDavid J. Schwartz
\n
DJS Law Group
\n
274 White Plains Road, Suite 1
\n
Eastchester, NY 10709
\n
Phone: 914-206-9742
\n
Email: David@djslawllp.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (\u201cInovio\u201d or \u201cthe Company\u201d) (NASDAQ: INO) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 10, 2023 to December 26, 2025 DEADLINE: April 7, 2026 CASE DETAILS: According to … <\/p>\n

Continue reading “Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-936458","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nInovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 INO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 INO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (\u201cInovio\u201d or \u201cthe Company\u201d) (NASDAQ: INO) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 10, 2023 to December 26, 2025 DEADLINE: April 7, 2026 CASE DETAILS: According to … Continue reading "Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T12:40:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\",\"datePublished\":\"2026-02-12T12:40:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/\"},\"wordCount\":357,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/\",\"name\":\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 INO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-02-12T12:40:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 INO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/","og_locale":"en_US","og_type":"article","og_title":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 INO - Market Newsdesk","og_description":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (\u201cInovio\u201d or \u201cthe Company\u201d) (NASDAQ: INO) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 10, 2023 to December 26, 2025 DEADLINE: April 7, 2026 CASE DETAILS: According to … Continue reading \"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-12T12:40:15+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO","datePublished":"2026-02-12T12:40:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/"},"wordCount":357,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/","name":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 INO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-02-12T12:40:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260212471736r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-ino\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 INO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=936458"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936458\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=936458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=936458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=936458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}